Antibiotic — Folate Synthesis Inhibitor
Pregnancy: D (first trimester); C (second/third trimester)
Trimethoprim (UTI)
Brand names: Monotrim
Adult dose
Dose: 200 mg twice daily for 7 days (uncomplicated UTI); 100 mg at night (prophylaxis)
Route: oral
Frequency: twice daily (treatment) or once nightly (prophylaxis)
Max: 400 mg/day
Avoid in first trimester (folate antagonism); prophylaxis dose 100 mg at night; increasing resistance — check local sensitivities
Paediatric dose
Dose: 2 mg/kg
Route: oral
Frequency: twice daily
Max: 200 mg twice daily
Concentration: 50 mg/5 ml suspension mg/ml
1–5 months: 25 mg BD; 6 months–5 years: 50 mg BD; 6–11 years: 100 mg BD; >12 years: 200 mg BD
Dose adjustments
Renal
50% dose if eGFR 15–30 ml/min; avoid if eGFR <15 ml/min
Hepatic
No dose adjustment required in mild-moderate hepatic impairment
Paediatric weight-based calculator
1–5 months: 25 mg BD; 6 months–5 years: 50 mg BD; 6–11 years: 100 mg BD; >12 years: 200 mg BD
Clinical pearls
- First-line for uncomplicated UTI per NICE NG112 only if local resistance <20%
- Avoid in first trimester — folate antagonist; use nitrofurantoin instead
- Hyperkalaemia mechanism: blocks ENaC channels like potassium-sparing diuretics
Contraindications
- First trimester pregnancy
- Blood dyscrasias
- Severe renal impairment (eGFR <15)
- Methotrexate (folate antagonism)
Side effects
- Nausea
- Vomiting
- Rash
- Pruritus
- Megaloblastic anaemia (prolonged use)
- Hyperkalaemia (at high doses — K-sparing effect)
Interactions
- Methotrexate (increased toxicity)
- Warfarin (enhanced anticoagulation)
- ACE inhibitors/ARBs (hyperkalaemia)
- Phenytoin (increased levels)
Monitoring
- FBC (prolonged use)
- Renal function
- Serum potassium (high doses)
Reference: BNFc; BNF 86; NICE NG112; PHE antimicrobial guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis